contraindications for tirzepatide Who Should Not Take Tirzepatide: Safety & Genetic Insights – PlexusDx Are there any contraindications to

Pancreas-related risks: a) Acute Pancreatitis: There have been reports of acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, in patients treated with GLP-1 receptor agonists

Clinical trials reveal that its weight loss results align closely with the injectable variant

Compounding legally prohibited in the US (FDA Category 2 from 2023 to April 2026

Many people taking GLP-1s are surprised to see pancreatic enzymes show up on a lab report and feel understandably anxious when they read that levels are "elevated" or "borderline high." This guide explains how GLP-1 medications affect the pancreas, what changes in amylase and lipase may mean, which blood tests matter most, when to test, and how to build a monitoring routine that keeps you informed